for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Deals

Roche has 60.4% of Spark, plans to wrap up takeover on Tuesday

FILE PHOTO: Swiss drugmaker Roche's logo is seen at their headquarters in Basel, Switzerland, January 28, 2016. REUTERS/Arnd Wiegmann

ZURICH (Reuters) - Swiss drugmaker Roche Holding ROG.S plans to complete on Tuesday its $4.3 billion takeover of Spark Therapeutics ONCE.O, it said, after winning U.S. regulatory approval for the long-delayed deal.

Roche said approximately 60.4% of the total number of shares of Spark’s common stock outstanding had been tendered in its offer for the gene therapy specialist.

Reporting by Michael Shields; editing by Thomas Seythal

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up